Elliptic Laboratories ASA

OSE:ELABS.OL

17.56 (NOK) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) NOK.

20242023202220212020201920182017
Operating Activities:
Net Income 17.047-38.001-39.302-13.092-15.557-16.96-33.236-43.48
Depreciation & Amortization 20.4084.63711.3178.3115.4394.3932.1151.935
Deferred Income Tax 000-0.012-0.549-0.431-0.38-0
Stock Based Compensation 5.4759.84212.46410.3494.0372.8723.7182.176
Change In Working Capital -48.592-20.3271.446-17.031-2.217-0.671-9.143-0.561
Accounts Receivables -50.324-20.118-11.469-28.599-0.451-0.742-10.56-1.827
Inventory 00000000
Accounts Payables 02.187-1.3612.040.154-1.6931.428-1.277
Other Working Capital 1.732-2.39614.2769.528-1.9211.764-0.0112.543
Other Non Cash Items -6.153-1.661.3170.6532.172.7511.7681.062
Operating Cash Flow -11.815-45.509-12.758-10.822-6.678-8.047-35.158-38.869
Investing Activities:
Investments In Property Plant And Equipment -30.716-0.514-23.327-17.61-15.103-11.097-8.739-1.37
Acquisitions Net 00000000
Purchases Of Investments 00000000
Sales Maturities Of Investments 00000000
Other Investing Activites 4.367-20.457000000
Investing Cash Flow -26.349-20.971-23.327-17.61-15.103-11.097-8.739-1.37
Financing Activities:
Debt Repayment -4-4-3.205-4-2.232025.007-2
Common Stock Issued 4.8359.4952.972162.218125.0443.015050
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities -4.968-3.289-3.457-11.418-35.618-4.626-1.768-1.062
Financing Cash Flow -4.1332.206-4.261146.887.1938.38923.23946.938
Other Information:
Effect Of Forex Changes On Cash 3.1061.6370.4160.059-0.0470.005-0.058-0.139
Net Change In Cash -39.192-62.637-39.932118.42765.36219.25-20.7166.559
Cash At End Of Period 76.39115.582178.219218.15199.72435.87316.62437.34